Robertson Wellness and Aesthetics in Beverly Hills, California, offers weight management within a physician-overseen wellness and aesthetics practice. For people researching semaglutide in Beverly Hills, Robertson Wellness presents a useful distinction between a clinic’s documented services and the medication-specific details that a search result alone cannot establish. Its business profile sits at the intersection of a local wellness offering and growing national interest in GLP-1 drugs, without providing a basis to measure the size of that intersection locally.

A Robertson Boulevard Clinic With a Broader Wellness Menu

Established around 2021, Robertson Wellness and Aesthetics operates at 150 N Robertson Blvd Suite 206, Beverly Hills, CA, 90211. Its stated offering encompasses IV therapy, NAD+, ozone, peptides, weight management and aesthetics under physician oversight. That combination defines the business more broadly than a single weight-management search term would suggest. The available description identifies several categories of care rather than a medication-specific practice, making the distinction important for readers assessing what the clinic actually advertises. Weight management is part of the documented offering; a particular semaglutide product, prescribing arrangement or treatment schedule is not established by the supplied business information.

The website also identifies an IV Membership, special offers, frequently asked questions and an Instagram presence. Those features describe how the business presents information and organizes parts of its offering, but they do not establish membership prices, participation levels or the terms of any particular offer. Similarly, physician oversight is part of the clinic’s stated description, not evidence of a named physician’s credentials or an individual patient’s treatment plan. The business invites consultation bookings. For a business profile, these distinctions keep the account anchored to the clinic’s documented activities rather than filling gaps with assumptions about how similarly described wellness practices operate.

National GLP-1 Uptake Does Not Measure Beverly Hills Demand

The national backdrop is substantial, but its geographic and clinical limits matter. KFF’s Health Tracking Poll on prescription drug costs, Trump administration actions and GLP-1 use reported that 12% of U.S. adults were currently using GLP-1 drugs in 2025, compared with 6% in May 2024. Those figures concern the broader drug class, not semaglutide alone, and neither figure measures Beverly Hills patients or Robertson Wellness and Aesthetics customers. No verified 2026 market-size figure or growth rate specifically for local semaglutide services is available in the supplied evidence. Doubling a national usage share therefore cannot responsibly be converted into a claim that this clinic’s business doubled, that Beverly Hills demand followed the same trajectory or that local providers gained equivalent revenue. A separate economic lens is available through U.S. Census Bureau business and economy data, but that resource should not be mistaken for a count of local semaglutide patients. The distinction matters commercially: national adoption describes a potential context for demand, while a local business assessment requires evidence about the actual market being discussed.

For Beverly Hills, the useful analysis is consequently about what can and cannot be inferred from the available information. A search such as “semaglutide beverly hills Robertson Wellness” combines a drug name, a city and a business, but it does not prove a prescribing relationship or document medication availability. Nor does the presence of weight management on a wellness menu show what share of appointments, revenue or staffing that category represents. Broader labor conditions can be examined through U.S. Bureau of Labor Statistics employment and wage data; those data serve a different purpose from a clinic-level demand assessment and are not presented here as evidence of this business’s workforce. This separation of evidence prevents a national pharmaceutical trend from becoming an unsupported local growth story. It also produces a more useful account of the business: Robertson Wellness participates in the weight-management category through its stated services, while the scale, composition and financial contribution of that activity remain unquantified in the information available for this article.

Weight Management Alongside NAD+, IV Therapy and Aesthetics

Robertson Wellness and Aesthetics describes a physician-overseen offering that includes weight management alongside IV therapy, NAD+, ozone, peptides and aesthetics. Its website also lists an IV Membership and special offers, and provides frequently asked questions. The clinic’s description invites prospective patients to book a consultation. Together, these documented elements establish the breadth of the advertised wellness offering without specifying medication brands, treatment eligibility, dosing, prices or anticipated outcomes. The service categories are the factual basis for describing the practice; the available business information does not supply a medication-level account of its weight-management work.

The resulting business picture is narrower than the national GLP-1 discussion, but more concrete: a Beverly Hills clinic established around 2021 lists weight management among several physician-overseen wellness and aesthetics services. Its relevance to a semaglutide search should not be confused with confirmation of a particular drug offering. For readers, the practical distinction is between identifying a business whose documented service category matches their inquiry and establishing the details of any proposed care. The first is supported by the clinic’s description; the second is not resolved by the information supplied for this article. That boundary allows local business coverage to acknowledge national interest without turning it into an unsupported claim about one practice. Further information about the clinic’s stated offerings and consultation booking is available at rwacenter.com.

Further reading from The Capital Front: Dr. Weight Loss of Atlanta Places Semaglutide Within a Broader Medical Weight-Loss Offering and Vibrant Body Lounge Places Body Sculpting on Enumclaw’s Business Map.